Back to search results

An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria Vaccine

Abroad (travel likely)Recruiting

Conditions

Malaria,Falciparum · Morality

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Unité de Recherche Clinique de Nanoro (URCN), Institut de Recherche en Sciences de la Santé, Direction Régionale du Centre-Ouest (IRSS-DRCO), Bousse, Bousse, Burkina Faso, Burkina Faso

    Contact: Study coordinator (Prof Halidou Tinto) · halidoutinto@gmail.com · +226 70346354

  • Centre de Recherche et de Lutte contre le Paludisme Institut National de Santé Publique, boulevard Nangui Abrogoua près État Major des Armées, Toumodi, Côte d’Ivoire

    Contact: Study coordinator (Prof William Yavo) · yavowilliam@yahoo.fr · +225 05 05 17 53 53

  • University of Ilorin Department of Pediatrics University of Ilorin Teaching Hospital, Ilorin, Nigeria, Yenagoa, Bayesla, Nigeria

    Contact: Study coordinator (Prof Olugbenga Mokuolu) · mokuolu@unilorin.edu.ng · +234-803-713-7407

  • Infectious Diseases Research Collaboration (IDRC), Uganda, Busia, Uganda, Uganda

    Contact: Study coordinator (Prof. Moses Kamya, MD) · mkamya@irdc-uganda.org · +256-414-530020

  • Makerere University College of Health Sciences, Mukono, Uganda

    Contact: Study coordinator (Dr Victoria Nankabirwa) · vnankabirwa@musph.ac.ug · +256-755-757-460
View source on ClinicalTrials.gov(opens in a new tab)